The 45-year-old, who has a Bachelor’s Degree in Business Administration Management from Webster University, London, has been with Biological E since 2001.
Hyderabad: Hyderabad-based vaccine company Biological E Limited (BE) on Saturday announced that its Corbevax Covid-19 vaccine has been approved by the Drug Controller General of India (DCGI) as a heterologous booster dose to individuals aged 18 years and above. This can be used after six months of administration of primary vaccination (two doses) of Covaxin […]
Hyderabad: Covid outbreak was an unprecedented situation and when Biological E was called to act upon it and develop a vaccine, the focus was on making the vaccine effective, safe, and affordable as health budgets were severely constrained in many countries. Speaking at a panel discussion on the first day of BioAsia titled ‘Two years […]
Hyderabad: Federation of Asian Biotech Associations [FABA] has announced the recipients of this year’s awards. Dr B S Bajaj Memorial FABA Special Award-2022 will be conferred upon Mahima Datla, MD, Biological E for introducing Corbevax vaccine in augmenting the fight against Covid-19 and B P Acharya, patron, FABA has been selected for the FABA Lifetime […]
The phase III clinical study to be conducted in 15 sites across India will evaluate the immunogenicity and safety of the SARS-CoV-2 Covid-19 vaccine for protection against the disease
IFC, a member of the World Bank Group, is providing a senior loan of up to $30 million to BioE to support the Hyderabad-based company's expansion of its range of low-priced, generic vaccines for routine immunisation of children, it added.
